Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In June 2026, Viking Therapeutics announced on June 24 the initiation of its Phase 1 clinical trial evaluating VK3019, an investigational dual amylin and calcitonin receptor agonist (DACRA)
And while they share some commonalities, theyre a lot different
We screen for contraindications at your initial consultation and tailor protocols to your specific health profile
Obesema 0.5mg Injection (1 Multi-dose Disposable Pen, 4 Needles, 4 Alcohol Swabs) is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight
US$ 29.35
US$ 28.20
US$ 22.20
US$ 24.98
US$ 23.89
US$ 27.14
US$ 28.49
